The Osel Devices IPO is a closed SME Bookbuilding offer (Fresh Capital) that opened on 16 September 2024. The Osel Devices IPO closed on 19 September 2024, with an issue price of ₹160 per share. The Osel Devices IPO has a face value of ₹10 and a lot size of 800 shares. The Osel Devices IPO is listed on 24 September 2024. The Osel Devices IPO allotment was scheduled for 20 September 2024.
On the financial front, the Osel Devices IPO reported revenue of ₹13,269 for 31 Mar 2024, compared with ₹8,196 for 31 Mar 2023. The Osel Devices IPO PAT was ₹1,305 against ₹466. The Osel Devices IPO net worth as of 31 Mar 2024 was ₹2,534.
Always verify The Osel Devices IPO details and GMP data with the official offer document before investing in the Osel Devices IPO.
Financial Summary
Amount in ₹ Lakhs
Metric
31 Mar 2024
31 Mar 2023
31 Mar 2022
Total Assets
9,864
4,902
3,312
Revenue
13,269
8,196
6,555
PAT
1,305
466
212
Net Worth
2,534
1,229
763
Reserves
1,380
1,043
577
Total Borrowing
2,545
1,782
863
Osel Devices IPO Financials FAQs
Revenue of Osel Devices (Amount in ₹ Lakhs) — 31 Mar 2024: 13,269; 31 Mar 2023: 8,196; 31 Mar 2022: 6,555. Profit after tax (PAT) — 31 Mar 2024: 1,305; 31 Mar 2023: 466; 31 Mar 2022: 212.
Total assets — 31 Mar 2024: 9,864; 31 Mar 2023: 4,902; 31 Mar 2022: 3,312. Net worth — 31 Mar 2024: 2,534; 31 Mar 2023: 1,229; 31 Mar 2022: 763. Reserves & surplus — 31 Mar 2024: 1,380; 31 Mar 2023: 1,043; 31 Mar 2022: 577. (Amount in ₹ Lakhs)
Total borrowing of Osel Devices (Amount in ₹ Lakhs) — 31 Mar 2024: 2,545; 31 Mar 2023: 1,782; 31 Mar 2022: 863.
The financials shown for Osel Devices IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
